Michael J. Schmitt

Array ( [id] => 11604075 [patent_doc_number] => 20170121376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'Preparation Methods for a Novel Generation of Biological Safe KLH Products Used for Cancer Treatment, for the Development of Conjugated Therapeutic Vaccines and as Challenging Agents' [patent_app_type] => utility [patent_app_number] => 15/318286 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12721 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225821 [patent_doc_number] => 20150110814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'COMBINATION THERAPIES WITH PSMA LIGAND CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/277367 [patent_app_country] => US [patent_app_date] => 2014-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25181 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14277367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187602 [patent_doc_number] => 09217013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Treatment of amyloidoses using myelin basic protein and fragments thereof' [patent_app_type] => utility [patent_app_number] => 14/265958 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 49 [patent_no_of_words] => 28891 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14265958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9615733 [patent_doc_number] => 20140205590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'BOTULINUM TOXIN TREATMENTS OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/247469 [patent_app_country] => US [patent_app_date] => 2014-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23299 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14247469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706833 [patent_doc_number] => 20160052980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'CRP40 FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/782141 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18952 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149246 [patent_doc_number] => 09181524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Modalities for the treatment of degenerative diseases of the retina' [patent_app_type] => utility [patent_app_number] => 14/227237 [patent_app_country] => US [patent_app_date] => 2014-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10561 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14227237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771116 [patent_doc_number] => 20140294779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA' [patent_app_type] => utility [patent_app_number] => 14/227305 [patent_app_country] => US [patent_app_date] => 2014-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14227305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919733 [patent_doc_number] => 20140322752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'REFOLDING TRANSFORMING GROWTH FACTOR BETA FAMILY PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/226481 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8289 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14226481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670440 [patent_doc_number] => 20140234303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'TREATMENT OF NEUROLOGICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/223315 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14526 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16926374 [patent_doc_number] => 11047848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Cellular discovery platform for neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 14/777013 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 59 [patent_no_of_words] => 82332 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16926374 [patent_doc_number] => 11047848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Cellular discovery platform for neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 14/777013 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 59 [patent_no_of_words] => 82332 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10670880 [patent_doc_number] => 20160017025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'METHODS AND COMPOSITIONS WITH IMMUNE THERAPY FOR TREATMENT OF DEMENTIA' [patent_app_type] => utility [patent_app_number] => 14/774974 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21035 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13251213 [patent_doc_number] => 10138286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Methods and compositions for inhibiting the effects of amyloid beta oligomers [patent_app_type] => utility [patent_app_number] => 14/772357 [patent_app_country] => US [patent_app_date] => 2014-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 110 [patent_no_of_words] => 36122 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685792 [patent_doc_number] => 20160031937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'NEURAL REGENERATION PEPTIDES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/773428 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19722 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10672272 [patent_doc_number] => 20160018417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'ASSAY AND METHOD FOR IDENTIFYING COMPOUNDS TO TREAT TAUOPATHIES' [patent_app_type] => utility [patent_app_number] => 14/773115 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15336 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757572 [patent_doc_number] => 20140288273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'MACROMOLECULAR COMPOSITIONS THAT CROSS THE BLOOD-BRAIN BARRIER AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/192792 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 47267 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14192792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634312 [patent_doc_number] => 20140212421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF MACROMOLECULES' [patent_app_type] => utility [patent_app_number] => 14/190788 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10318 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919712 [patent_doc_number] => 20140322731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/190525 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 47747 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10792964 [patent_doc_number] => 20160139120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'RAGE AS A C1Q RECEPTOR, METHODS AND APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/767561 [patent_app_country] => US [patent_app_date] => 2014-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 27976 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467138 [patent_doc_number] => 20150352153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'REPAIR OF PERIPHERAL NERVE INJURY' [patent_app_type] => utility [patent_app_number] => 14/764450 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10375 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764450 [rel_patent_id] =>[rel_patent_doc_number] =>)